Form 8-K - Current report:
SEC Accession No. 0001564590-15-002511
Filing Date
2015-04-10
Accepted
2015-04-10 08:54:15
Documents
1
Period of Report
2015-04-08
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K lgnd-8k_20150408.htm 8-K 28390
  Complete submission text file 0001564590-15-002511.txt   29491
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 15762676
SIC: 2834 Pharmaceutical Preparations